(NEW YORK) — Pharmaceutical company Allergan announced a recall of its BIOCELL textured breast implants and tissue expanders on Wednesday, following a request from the Food and Drug Administration.
Judges in Amsterdam have rejected a claim for collective damages against pharmaceutical company Allergan, now part of AbbVie, ...
Allergan is taking this action as a precaution following notification of recently updated global safety information concerning the uncommon incidence of breast implant-associated anaplastic large cell ...
WASHINGTON (AP) — Breast implant maker Allergan Inc. issued a worldwide recall Wednesday for certain textured models after regulators alerted the company to a heightened cancer risk with the devices.
Worldwide, 573 cases and 33 deaths from the cancer have been reported, with 481 of the cases clearly attributed to Allergan Biocell implants, the FDA said. Of the 33 deaths, the agency said its data ...
SILVER SPRING, Md., July 24, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today took significant action to protect women from breast implant-associated anaplastic large cell lymphoma ...
The manufacturer’s textured products are linked to large cell lymphoma DES MOINES, Iowa--(BUSINESS WIRE)-- Allergan, the manufacturers of BIOCELL textured “gummy” breast implants, is the target of a ...
Allergan Korea on Monday rolled out compensation plans for patients treated with its breast implants, but fell short of expectations. The pharmaceutical firm’s rough-textured Natrelle Biocell Textured ...
WASHINGTON (AP) — Medical device maker Allergan Inc. is recalling a type of breast implant linked to a rare form of cancer. The company Wednesday announced a worldwide recall of implants with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback